{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:37:16Z","timestamp":1794062236893,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajoc.2021.101111","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:20:07Z","timestamp":1620994807000},"page":"101111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study"],"prefix":"10.1016","volume":"23","author":[{"given":"Connie M.","family":"Sears","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Turbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem S.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Cockerham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Kossler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajoc.2021.101111_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03345280","article-title":"Graves' ophthalmopathy: state of the art and perspectives","volume":"27","author":"Bartalena","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"10.1016\/j.ajoc.2021.101111_bib2","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2015-4294","article-title":"Risk factors for Graves' orbitopathy; the Australian thyroid-associated orbitopathy research (ATOR) study","volume":"101","author":"Khong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ajoc.2021.101111_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0161-6420(88)32978-7","article-title":"Dysthyroid optic neuropathy. The crowded orbital apex syndrome","volume":"95","author":"Neigel","year":"1988","journal-title":"Ophthalmology"},{"issue":"4S Suppl 1","key":"10.1016\/j.ajoc.2021.101111_bib4","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/IOP.0000000000001146","article-title":"Dysthyroid optic neuropathy","volume":"34","author":"Saeed","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.ajoc.2021.101111_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archopht.1981.03930010807002","article-title":"Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography","volume":"99","author":"Kennerdell","year":"1981","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2021.101111_bib6","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.ophtha.2012.04.021","article-title":"Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis","volume":"119","author":"Weis","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000486828","article-title":"Prevalence of radiological signs of dysthyroid optic neuropathy in magnetic resonance imaging in patients with active, moderate-to-severe, and very severe Graves orbitopathy","volume":"7","author":"Rutkowska-Hinc","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17469899.2017.1276444","article-title":"Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management","volume":"12","author":"Blandford","year":"2017","journal-title":"Expet Rev Ophthalmol"},{"issue":"18","key":"10.1016\/j.ajoc.2021.101111_bib9","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41433-018-0321-y","article-title":"Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis","volume":"33","author":"Douglas","year":"2019","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.ajoc.2021.101111_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajoc.2021.101111_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2005.02345.x","article-title":"Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial","volume":"63","author":"Wakelkamp","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5603\/EP.a2016.0018","article-title":"Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy","volume":"67","author":"Mi\u015bkiewicz","year":"2016","journal-title":"Endokrynol Pol"},{"issue":"9","key":"10.1016\/j.ajoc.2021.101111_bib14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41433-020-0897-x","article-title":"Evaluation of medical and surgical decompression in patients with dysthyroid optic neuropathy","volume":"34","author":"Garip Kuebler","year":"2020","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.ajoc.2021.101111_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ajo.2014.02.044","article-title":"Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease","volume":"157","author":"Shams","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2021.101111_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archopht.1968.03850040281009","article-title":"Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction","volume":"79","author":"Day","year":"1968","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2021.101111_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archopht.1978.03910060033007","article-title":"Dysthyroid optic neuropathy. Clinical profile and rationale for management","volume":"96","author":"Trobe","year":"1978","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0002-9394(14)77786-4","article-title":"A retrospective review of 26 cases of dysthyroid optic neuropathy","volume":"96","author":"Panzo","year":"1983","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2021.101111_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0161-6420(89)32784-9","article-title":"Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy","volume":"96","author":"Guy","year":"1989","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2021.101111_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1076\/orbi.20.4.275.2612","article-title":"Methylprednisolone pulse therapy for patients with dysthyroid optic neuropathy","volume":"20","author":"Ph Mourits","year":"2001","journal-title":"Orbit"},{"issue":"4","key":"10.1016\/j.ajoc.2021.101111_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/jop.2005.21.328","article-title":"Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome","volume":"21","author":"Hart","year":"2005","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.ajoc.2021.101111_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3928\/15428877-20060701-04","article-title":"Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy","volume":"37","author":"Ben Simon","year":"2006","journal-title":"Ophthalmic Surg Laser Imag"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3341\/kjo.2012.26.2.73","article-title":"Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy","volume":"26","author":"Jeon","year":"2012","journal-title":"Kor J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2021.101111_bib24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/thy.2013.0445","article-title":"Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy","volume":"24","author":"Curr\u00f2","year":"2014","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ajoc.2021.101111_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/01676830.2014.938168","article-title":"Survey of common practices among oculofacial surgeons in the Asia-Pacific region: graves' orbitopathy","volume":"33","author":"Sundar","year":"2014","journal-title":"Orbit"},{"issue":"5","key":"10.1016\/j.ajoc.2021.101111_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/IOP.0000000000000356","article-title":"Compressive optic neuropathy and repeat orbital decompression: a case series","volume":"31","author":"Kauh","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ajoc.2021.101111_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"European group on Graves' orbitopathy (EUGOGO). The 2016 European thyroid association\/European group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.ajoc.2021.101111_bib28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41433-018-0144-x","article-title":"A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom","volume":"32","author":"Wong","year":"2018","journal-title":"Eye"},{"issue":"11","key":"10.1016\/j.ajoc.2021.101111_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.18240\/ijo.2019.11.12","article-title":"The effect of intravenous high-dose glucocorticoids and orbital decompression surgery on sight-threatening thyroid-associated ophthalmopathy","volume":"12","author":"Wen","year":"2019","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-37-2-276","article-title":"Supervoltage orbital radiotherapy for Graves' ophthalmopathy","volume":"37","author":"Donaldson","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ajoc.2021.101111_bib31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9394(14)76158-6","article-title":"Supervoltage orbital radiotherapy in 36 cases of Graves' disease","volume":"113","author":"Lloyd","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajoc.2021.101111_bib32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajoc.2021.101111_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/105072502753600223","article-title":"Orbital radiotherapy for Graves' ophthalmopathy","volume":"12","author":"Bartalena","year":"2002","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ajoc.2021.101111_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/01676830.2011.603458","article-title":"Optic neuropathy following orbital irradiation for Graves' ophthalmopathy: a Case report and literature review","volume":"31","author":"S\u00e1nchez-Orgaz","year":"2012","journal-title":"Orbit"},{"issue":"4S Suppl 1","key":"10.1016\/j.ajoc.2021.101111_bib35","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/IOP.0000000000001074","article-title":"Radiotherapy for active thyroid eye disease","volume":"34","author":"Godfrey","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ajoc.2021.101111_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IOP.0000000000001003","article-title":"Orbital radiotherapy combined with corticosteroid treatment for thyroid eye disease-compressive optic neuropathy","volume":"34","author":"Gold","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4S","key":"10.1016\/j.ajoc.2021.101111_bib37","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ophtha.2020.01.031","article-title":"A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy","volume":"127","author":"Gorman","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2021.101111_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.2006.0267","article-title":"Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy","volume":"17","author":"Le Moli","year":"2007","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.ajoc.2021.101111_bib39","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves' ophthalmopathy: is it safe? A long-term follow-up study","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophthalmology"},{"issue":"9104","key":"10.1016\/j.ajoc.2021.101111_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(05)78494-4","article-title":"Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy","volume":"351","author":"Nygaard","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajoc.2021.101111_bib41","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1097\/IOP.0000000000001831","article-title":"Teprotumumab for dysthyroid optic neuropathy: early response to therapy","volume":"37","author":"Sears","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.ajoc.2021.101111_bib42","doi-asserted-by":"crossref","first-page":"100744","DOI":"10.1016\/j.ajoc.2020.100744","article-title":"Early experience with teprotumumab for chronic thyroid eye disease","volume":"19","author":"Ozzello","year":"2020","journal-title":"Am J Ophthalmol Case Rep"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993621001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993621001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:00:49Z","timestamp":1762527649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993621001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"alternative-id":["S2451993621001201"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2021.101111","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2021.101111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101111"}}